RETATRUTIDE (GLP-3)

Retatrutide, identified by its compound code LY-3437943, is an investigational peptide studied in research environments for its unique triple receptor interaction profile. Its structure and mechanism of action make it of interest in studies focused on hormonal receptor pathways and regulatory peptides. As a research chemical, it is commonly used in preclinical studies examining metabolic signaling and energy regulation models in controlled lab conditions.

Original price was: $309.00.Current price is: $289.00. / month

FREE Shipping on orders over $200

MOLECULAR FORMULA:

C212H350N56O78S

Quantity Discounts Available

Product Usage: For Research Use Only – Not for Human or Veterinary Use

This product is not a drug, food, cosmetic, or dietary supplement and has not been evaluated by the FDA. It is strictly intended for in vitro research by qualified professionals. Any use in humans or animals is strictly prohibited and may violate federal, state, or local laws, including the Federal Food, Drug, and Cosmetic Act. No therapeutic or diagnostic application is implied or permitted. The purchaser assumes all responsibility for compliance with applicable regulations.

The GHRH/GHRP Synergistic Axis

The CJC-1295 (No DAC) + Ipamorelin Blend is a lyophilized synergistic complex designed for researchers studying the maximum potential of endogenous growth hormone release. By combining a GHRH (Growth Hormone Releasing Hormone) analog with a GHRP (Growth Hormone Releasing Peptide), scientists can evaluate the ‘amplifier effect’ that occurs when both receptor types are activated simultaneously. This reagent is specifically valued for its precision; Ipamorelin provides highly selective GH release, while the No DAC modification of the CJC-1295 ensures the natural pulsatile rhythm is preserved rather than suppressed. This allows for the study of metabolic shifts, tissue architectural restoration, and lipid oxidation in a controlled, laboratory environment. Supplied as a purified powder, it is intended strictly for laboratory research; it is not for human or veterinary administration.

Chemical Info

CAS Number	863288-34-0	170851-70-4
PubChem CID	91976842	9831659
Molecular Weight	3367.9 g/mol	711.9 g/mol
Molecular Formula	C₁₅₂H₂₅₂N₄₄O₄₂	C₃₈H₄₉N₉O₅
Synonyms	Modified GRF (1-29), Mod GRF 1-29, NNC-26-0161
Purity	≥ 99% HPLC

Storage

Store in lyophilized form at -20°C to maintain compound stability.

Store protected from direct light exposure to reduce degradation.

Keep totally dry and avoid moisture exposure prior to reconstitution.

Keep vial tightly sealed when not in use to preserve integrity.

The GHRH/GHRP Synergistic Axis

The primary focus of this blend is the investigation of ‘Dual-Receptor Synergism.’ In pituitary research, it has been observed that GHRH and GHRP work through different intracellular pathways (cAMP and PLC/IP3, respectively). When administered together, they have been shown to produce a GH release that is significantly greater than the sum of the two parts. Researchers use this blend to determine the optimal ratios required to maximize this ‘Double Pulse’ while avoiding receptor desensitization.

Metabolic Signaling & Body Composition

In metabolic studies, this complex is utilized to observe the secondary effects of elevated GH on the IGF-1 axis. By stimulating the liver to produce IGF-1 in a pulsatile manner, researchers can monitor changes in nitrogen retention, protein synthesis, and collagen deposition. This research is vital for understanding how specific secretagogue stacks can influence the structural restoration of skeletal muscle and connective tissue in animal models of atrophy or injury.